| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Endocrinology (D.G.M., B.K., N.B., G.A.K., M.G., M.K., A.B.G.), St. Bartholomews Hospital, London EC1A 7BE, United Kingdom; Division of Cancer Sciences and Molecular Pathology (A.M.M., R.F.), Medical Faculty, University of Glasgow, Glasgow G4 0SF, United Kingdom; Academic Unit of Endocrinology (T.H.J.), Division of Genomic Medicine, University of Sheffield, Sheffield S10 2RX, United Kingdom; National Institute of Neurology and Neurosurgery (S.B., M.P.), Queen Square, London WC1N 3BG, United Kingdom; National Institute of Neurosurgery (S.C., Z.H.), 1145 Budapest, Hungary; and Research Centre for Endocrinology and Metabolism (J.-O.J.), Sahlgrenska University Hospital, 413 45 Göteborg, Sweden
Address all correspondence and requests for reprints to: Professor A. B. Grossman, Endocrine Oncology, Department of Endocrinology, St. Bartholomews Hospital, London EC1A 7BE, United Kingdom. E-mail: a.b.grossman{at}qmul.ac.uk.
The ACTH receptor (ACTH-R) is the second member of the melanocortin (MC-2) receptor family that includes five seven-transmembrane G protein-coupled receptors and has been shown to be predominantly expressed in the adrenal cortex. It has been postulated that ACTH may regulate its own secretion through ultra-short-loop feedback within the pituitary. ACTH-secreting adenomas are characterized by resistance to glucocorticoid feedback, and they may have dysregulated ACTH feedback. We therefore investigated the ACTH-R in normal and adenomatous human pituitary tissue. We report here the identification of ACTH-R mRNA in the human pituitary gland, which was confirmed by direct sequencing. We studied the expression of the ACTH-R in 23 normal pituitary specimens and 53 pituitary adenomas (22 ACTH-secreting, nine GH-secreting, eight prolactin-secreting, one TSH-secreting, one FSH-secreting, 10 nonfunctioning, and two silent corticotroph adenomas), using the sensitive technique of real-time quantitative PCR. Contamination of ACTH-secreting adenomas and nonfunctioning pituitary adenomas with nonadenomatous tissue was excluded by lack of Pit-1 expression. ACTH-R mRNA was detected in all normal pituitary specimens, and in situ hybridization colocalized expression to ACTH staining cells only. However, ACTH-R mRNA levels were undetectable in 16 of 22 ACTH-secreting tumors and in both silent corticotroph tumors. Diagnostic preoperative plasma ACTH levels were significantly lower in the ACTH-R positive ACTH-secreting tumors, compared with those who were ACTH-R negative (P = 0.0006). Direct sequencing of the coding region of the ACTH-R in cDNA from three ACTH-secreting tumors positively expressing the receptor showed no mutations, as did sequencing of genomic DNA in three receptor negative ACTH-secreting tumors and the two silent corticotrophs. These results provide further evidence compatible with an ACTH feedback loop in the pituitary and suggest that loss of expression of the ACTH-R in corticotroph adenomas of patients with Cushings disease may play a role in the resistance to feedback of the pituitary-adrenal axis seen in these patients.
D.G.M. and M.G. were supported by the Joint Research Board of St. Bartholomews Hospital. B.K. was supported by the Cancer Research Committee of St. Bartholomews Hospital. M.K. is a Medical Research Council Clinical Scientist.
Abbreviations: ACTH-R, ACTH receptor; DIG, digoxigenin; dNTP, deoxynucleotide triphosphate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; gDNA, genomic DNA; ISH, in situ hybridization; NFPA, nonfunctioning pituitary adenoma; POMC, proopiomelanocortin; PRL, prolactin; RQ-PCR, real-time quantitative PCR; RT, reverse transcription; SSC, saline sodium citrate; UTR, untranslated region.
This article has been cited by other articles:
![]() |
M. Doufexis, H. L. Storr, P. J. King, and A. J. L. Clark Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus FASEB J, December 1, 2007; 21(14): 4095 - 4100. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A Noon, A. Bakmanidis, A. J L Clark, P. J O'Shaughnessy, and P. J King Identification of a novel melanocortin 2 receptor splice variant in murine adipocytes: implications for post-transcriptional control of expression during adipogenesis J. Mol. Endocrinol., December 1, 2006; 37(3): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Woo, A. M. Isidori, W. Z. Wat, G. A. Kaltsas, F. Afshar, I. Sabin, P. J. Jenkins, J. P. Monson, G. M. Besser, and A. B. Grossman Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting Macroadenomas J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4963 - 4969. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Morris, M. Musat, S. Czirjak, Z. Hanzely, D. M Lillington, M. Korbonits, and A. B Grossman Differential gene expression in pituitary adenomas by oligonucleotide array analysis Eur. J. Endocrinol., July 1, 2005; 153(1): 143 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Noon, A. J. L. Clark, and P. J. King A Peroxisome Proliferator-response Element in the Murine mc2-r Promoter Regulates Its Transcriptional Activation during Differentiation of 3T3-L1 Adipocytes J. Biol. Chem., May 28, 2004; 279(22): 22803 - 22808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |